Investing Profile

Peter Thompson

InvestorVC

Partner at Orbimed

orbimed.comBellevue, Washington
Photo of Peter Thompson, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
10
$18B
CompanyStageDateRound SizeTotal Raised
ReCode Therapeutics
Series BOct 2021$80M
Series AMar 2020$80M
$160M
Co-investors: Rana Al-Hallaq (Pfizer Venture Investments), Ed Hurwitz (MPM Capital), Helen Kim (Vida Ventures)
Carrot Fertility
Series CAug 2021$75M
$110M
Co-investors: Jay Chen (Tiger Global Management), Reid Christian (CRV), Charles Hudson (Precursor Ventures), Dafina Toncheva (USVP), Stephanie Palmeri (NextView Ventures), Sara Thomas Deshpande (Maven Ventures), Terrence Rohan (Otherwise Fund), Arjun Sethi (Tribe Capital), Chloe Sladden (#ANGELS (Hashtag ANGELS))
Janux Therapeutics
Series BApr 2021$130M
Series AMar 2021$56M
$180M
Co-investors: Jake Simson (RA Capital)
Edgewise Therapeutics
Series CDec 2020$95M
$95M
PMV Pharmaceuticals
Series DAug 2020$70M
$70M
Aspen Neuroscience
Series AApr 2020$70M
$70M
Co-investors: Sam Altman (Apollo Projects)
Cleave Therapeutics
Series CAug 2019$12M
$90M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Robert Garland (New Enterprise Associates (NEA)), Andrew Schwab (5am Ventures), Kush Parmar (5am Ventures), Marc Singer (Osage University Partners), Larry Lasky (The Column Group), Alfred Scheidegger (Nextech Invest)
Synthorx
Series CApr 2018$63M
$73M
Co-investors: Andrew Levin (RA Capital)